Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,805 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Teirstein PS, Kao J, Watkins M, Tannenbaum MA, Laufer N, Chang M, Mehran R, Dangas G, Russell ME, Ellis SG, Stone GW. Teirstein PS, et al. Among authors: kao j. Am J Cardiol. 2005 Aug 15;96(4):500-5. doi: 10.1016/j.amjcard.2005.04.009. Am J Cardiol. 2005. PMID: 16098300 Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
Platelet resistance to antiplatelet drugs.
Kumar A, Kao J. Kumar A, et al. Among authors: kao j. Recent Pat Cardiovasc Drug Discov. 2009 Jun;4(2):98-108. doi: 10.2174/157489009788452959. Recent Pat Cardiovasc Drug Discov. 2009. PMID: 19519552 Review.
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C.
Hong CM, Su TH, Hsu SJ, Tseng TC, Liu CH, Yang HC, Kao JH, Chen PJ, Cheng PN, Hung CH, Peng CY, Chen CH, Lin CY, Kuo HT, Lin HC, Huang YH, Chen CY, Lin CL, Tsai PC, Zeng YS, Dai CY, Chuang WL, Huang JF, Huang CF, Yeh ML, Yu ML, Liu CJ. Hong CM, et al. Among authors: kao jh. J Formos Med Assoc. 2024 Nov 1:S0929-6646(24)00511-4. doi: 10.1016/j.jfma.2024.10.024. Online ahead of print. J Formos Med Assoc. 2024. PMID: 39488497
1,805 results